Key elements of metabolomics in the study of biomarkers of diabetes

Diabetologia

Volumn 59, Issue 12, 2016, Pages 2497-2502

  Adamski, Jerzy ^a,b,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarker; Diabetes; Mass spectrometry; Metabolism; Metabolomics; Nuclear magnetic resonance

Indexed keywords

BIOLOGICAL MARKER;

DIABETES MELLITUS; GAS CHROMATOGRAPHY; GENETICS; HUMAN; LIQUID CHROMATOGRAPHY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVIEW; TANDEM MASS SPECTROMETRY; ANIMAL; FEMALE; MALE; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

ANIMALS; BIOMARKERS; DIABETES MELLITUS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLOMICS;

EID: 84990821960     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-4044-y     Document Type: Review

References (39)

1. Tweeddale H, Notley-McRobb L, Ferenci T (1998) Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool (“metabolome”) analysis. J Bacteriol 180:5109–5116
2. Pena MJ, de Zeeuw D, Mischak H et al (2015) Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc Eur Ren Assoc 30(Suppl 4):iv86-iv95
3. Wurtz P, Havulinna AS, Soininen P et al (2015) Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation 131:774–785
4. Janzer A, German NJ, Gonzalez-Herrera KN, Asara JM, Haigis MC, Struhl K (2014) Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proc Natl Acad Sci U S A 111:10574–10579
5. Lord SR, Patel N, Liu D et al (2015) Neoadjuvant window studies of metformin and biomarker development for drugs targeting cancer metabolism. J Natl Cancer Inst Monogr 2015:81–86
6. Meadows NA, Morrison A, Brindley DA, Schuh A, Barker RW (2015) An evaluation of regulatory and commercial barriers to stratified medicine development and adoption. Pharmacogenomics J 15:6–12
7. Suhre K, Romisch-Margl W, de Angelis MH, Adamski J, Luippold G, Augustin R (2011) Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. J Biomol Screen 16:467–475
8. Kastenmüller G, Raffler J, Gieger C, Suhre K (2015) Genetics of human metabolism: an update. Hum Mol Genet 24:R92–R101
9. Suhre K, Shin SY, Petersen AK et al (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54–60
10. Mittelstrass K, Ried JS, Yu Z et al (2011) Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 7:e1002215
11. Yu Z, Zhai G, Singmann P et al (2012) Human serum metabolic profiles are age dependent. Aging Cell 11:960–967
12. Floegel A, Wientzek A, Bachlechner U et al (2014) Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study. Int J Obes (Lond) 38:1388–1396
13. Lankinen M, Schwab U, Seppanen-Laakso T et al (2011) Metabolomic analysis of plasma metabolites that may mediate effects of rye bread on satiety and weight maintenance in postmenopausal women. J Nutr 141:31–36
14. Altmaier E, Fobo G, Heier M et al (2014) Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur J Epidemiol 29:325–336
15. Krug S, Kastenmüller G, Stuckler F et al (2012) The dynamic range of the human metabolome revealed by challenges. FASEB J 26:2607–2619
16. Jaremek M, Yu Z, Mangino M et al (2013) Alcohol-induced metabolomic differences in humans. Transl Psychiatry 3:e276
17. Wang-Sattler R, Yu Y, Mittelstrass K et al (2008) Metabolic profiling reveals distinct variations linked to nicotine consumption in humans—first results from the KORA study. PLoS ONE 3:e3863
18. Altmaier E, Kastenmüller G, Romisch-Margl W et al (2009) Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Mol Nutr Food Res 53:1357–1365
19. Chua EC, Shui G, Lee IT et al (2013) Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans. Proc Natl Acad Sci U S A 110:14468–14473
20. Floegel A, Drogan D, Wang-Sattler R et al (2011) Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PLoS One 6:e21103
21. Yousri NA, Kastenmuller G, Gieger C et al (2014) Long term conservation of human metabolic phenotypes and link to heritability. Metabolomics 10:1005–1017
22. Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453
23. Wang TJ, Ngo D, Psychogios N et al (2013) 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 123:4309–4317
24. Yamanouchi T, Ogata N, Tagaya T et al (1996) Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347:1514–1518
25. Yousri NA, Mook-Kanamori DO, Selim MM et al (2015) A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control. Diabetologia 58:1855–1867
26. Park S, Sadanala KC, Kim EK (2015) A metabolomic approach to understanding the metabolic link between obesity and diabetes. Mol Cells 38:587–596
27. Suhre K (2014) Metabolic profiling in diabetes. J Endocrinol 221:R75–R85
28. Roberts LD, Koulman A, Griffin JL (2014) Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol 2:65–75
29. Tzoulaki I, Ebbels TM, Valdes A, Elliott P, Ioannidis JP (2014) Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. Am J Epidemiol 180:129–139
30. Pena MJ, Lambers Heerspink HJ, Hellemons ME et al (2014) Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with type 2 diabetes mellitus. Diabet Med: J Br Diabet Assoc 31:1138–1147
31. Yu Z, Kastenmuller G, He Y et al (2011) Differences between human plasma and serum metabolite profiles. PLoS One 6:e21230
32. Do KT, Kastenmuller G, Mook-Kanamori DO et al (2015) Network-based approach for analyzing intra- and interfluid metabolite associations in human blood, urine, and saliva. J Proteome Res 14:1183–1194
33. Plebani M (2006) Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 44:750–759
34. Fliniaux O, Gaillard G, Lion A, Cailleu D, Mesnard F, Betsou F (2011) Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks. J Biomol NMR 51:457–465
35. Hyotylainen T (2012) Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications. Expert Rev Mol Diagn 12:527–538
36. Artati A, Prehn C, Möller G, Adamski J (2012) Assay tools for metabolomics. In: Suhre K (ed) Genetics meets metabolomics: from experiment to systems biology. Springer, New York, pp 13–38
37. Suhre K, Meisinger C, Doring A et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5:e13953
38. Psychogios N, Hau DD, Peng J et al (2011) The human serum metabolome. PLoS One 6:e16957
39. Bouatra S, Aziat F, Mandal R et al (2013) The human urine metabolome. PLoS One 8:e73076